Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancers

Sauveur-Michel Maira, Frédéric Stauffer, Josef Brueggen, Pascal Furet, Christian Schnell, Christine Fritsch, Saskia Brachmann, Patrick Chène, Alain De Pover, Kevin Schoemaker, Doriano Fabbro, Daniela Gabriel, Marjo Simonen, Leon Murphy, Peter Finan, William Sellers, Carlos García-Echeverría, Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity Molecular Cancer Therapeutics. ,vol. 7, pp. 1851- 1863 ,(2008) , 10.1158/1535-7163.MCT-08-0017

J. Luo, C. L. Sobkiw, N. M. Logsdon, J. M. Watt, S. Signoretti, F. O'Connell, E. Shin, Y. Shim, L. Pao, B. G. Neel, R. A. DePinho, M. Loda, L. C. Cantley, Modulation of epithelial neoplasia and lymphoid hyperplasia in PTEN+/- mice by the p85 regulatory subunits of phosphoinositide 3-kinase Proceedings of the National Academy of Sciences of the United States of America. ,vol. 102, pp. 10238- 10243 ,(2005) , 10.1073/PNAS.0504378102

Astrid Lièvre, Jean-Baptiste Bachet, Delphine Le Corre, Valérie Boige, Bruno Landi, Jean-François Emile, Jean-François Côté, Gorana Tomasic, Christophe Penna, Michel Ducreux, Philippe Rougier, Frédérique Penault-Llorca, Pierre Laurent-Puig, KRAS Mutation Status Is Predictive of Response to Cetuximab Therapy in Colorectal Cancer Cancer Research. ,vol. 66, pp. 3992- 3995 ,(2006) , 10.1158/0008-5472.CAN-06-0191

Anne-Karina T. Perl, Jay W. Tichelaar, Jeffrey A. Whitsett, Conditional gene expression in the respiratory epithelium of the mouse Transgenic Research. ,vol. 11, pp. 21- 29 ,(2002) , 10.1023/A:1013986627504

Leisa Johnson, Kim Mercer, Doron Greenbaum, Roderick T. Bronson, Denise Crowley, David A. Tuveson, Tyler Jacks, Somatic activation of the K-ras oncogene causes early onset lung cancer in mice Nature. ,vol. 410, pp. 1111- 1116 ,(2001) , 10.1038/35074129

Sreenath V. Sharma, Michael A. Fischbach, Daniel A. Haber, Jeffrey Settleman, “Oncogenic Shock”: Explaining Oncogene Addiction through Differential Signal Attenuation: Fig. 1. Clinical Cancer Research. ,vol. 12, pp. 4392s- 4395s ,(2006) , 10.1158/1078-0432.CCR-06-0096

Surbhi Gupta, Antoine R. Ramjaun, Paula Haiko, Yihua Wang, Patricia H. Warne, Barbara Nicke, Emma Nye, Gordon Stamp, Kari Alitalo, Julian Downward, Binding of Ras to Phosphoinositide 3-Kinase p110α Is Required for Ras- Driven Tumorigenesis in Mice Cell. ,vol. 129, pp. 957- 968 ,(2007) , 10.1016/J.CELL.2007.03.051

David A Fruman, Scott B Snapper, Claudine M Yballe, Laurie Davidson, Jonathan Y Yu, Frederick W Alt, Lewis C Cantley, Impaired B Cell Development and Proliferation in Absence of Phosphoinositide 3-Kinase p85α Science. ,vol. 283, pp. 393- 397 ,(1999) , 10.1126/SCIENCE.283.5400.393

Danan Li, Takeshi Shimamura, Hongbin Ji, Liang Chen, Henry J. Haringsma, Kate McNamara, Mei-Chih Liang, Samanthi A. Perera, Sara Zaghlul, Christa L. Borgman, Shigeto Kubo, Masaya Takahashi, Yanping Sun, Lucian R. Chirieac, Robert F. Padera, Neal I. Lindeman, Pasi A. Jänne, Roman K. Thomas, Matthew L. Meyerson, Michael J. Eck, Jeffrey A. Engelman, Geoffrey I. Shapiro, Kwok-Kin Wong, Bronchial and peripheral murine lung carcinomas induced by T790M-L858R mutant EGFR respond to HKI-272 and rapamycin combination therapy Cancer Cell. ,vol. 12, pp. 81- 93 ,(2007) , 10.1016/J.CCR.2007.06.005

Yanan Yang, Kentaro Iwanaga, Maria Gabriela Raso, Marie Wislez, Amy E. Hanna, Eric D. Wieder, Jeffrey J. Molldrem, Ignacio I. Wistuba, Garth Powis, Francesco J. Demayo, Carla F. Kim, Jonathan M. Kurie, Phosphatidylinositol 3-Kinase Mediates Bronchioalveolar Stem Cell Expansion in Mouse Models of Oncogenic K-ras-Induced Lung Cancer PLoS ONE. ,vol. 3, pp. e2220- ,(2008) , 10.1371/JOURNAL.PONE.0002220